Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intellipharmaceutics International Inc (NASDAQ:IPCI)

1.03
Delayed Data
As of Oct 16
 -0.03 / -2.83%
Today’s Change
0.81
Today|||52-Week Range
3.35
-63.73%
Year-to-Date
New Strong Sell Stocks for October 11th
Oct 11 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close1.06
Today’s open1.00
Day’s range1.00 - 1.07
Volume243,384
Average volume (3 months)378,386
Market cap$32.9M
Dividend yield--
Data as of 10/16/2017

Growth & Valuation

Earnings growth (last year)-22.58%
Earnings growth (this year)+45.61%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)-45.11%
P/E ratio--
Price/Sales32.70
Price/Book28.29

Competitors

 Today’s
change
Today’s
% change
TNXPTonix Pharmaceutical...-0.12-2.62%
VKTXViking Therapeutics ...-0.19-8.33%
SLNOSoleno Therapeutics ...+0.00+0.00%
CBLICleveland Biolabs In...-0.02-0.63%
Data as of 10/16/2017

Financials

Last reporting dateOctober 10, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$2.2M
Annual profit (last year)-$10.1M
Net profit margin-451.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO &
Co-Chief Scientific Officer
Isa Odidi
President, Chief Operating Officer &
Director
Amina Odidi
Corporate headquarters
Toronto, Ontario

Forecasts